HOME >> BIOLOGY >> NEWS
International research group led by UMass scientist sequences genome of ubiquitous microbe

AMHERST, Mass. - A team of scientists at the University of Massachusetts led by microbial genetics professor Shiladitya DasSarma, in collaboration with noted molecular biotechnologist Leroy Hood of the Institute of Systems Biology (ISB), Seattle, Wash., has completed the genome sequence of Halobacterium species NRC-1, an "extremophilic" microorganism that grows best in an environment 10 times saltier than sea water. The achievement will be published in the Oct. 3 edition of the journal Proceedings of the National Academy of Sciences (PNAS).

DasSarma and Hood led a consortium of researchers from 12 universities and research centers in the U.S., Canada, and the U.K., on the three-year, $1.2-million project funded by the National Science Foundation (NSF). Hood may be best known as the creator of DNA sequencing technology. Forty-three researchers, including the team leaders, participated in producing the manuscript outlining their findings. Wailap Victor Ng, a UMass alumnus currently on the faculty of ISB, was first author of the manuscript.

"Genome studies on Halobacterium should contribute toward some of the greatest unsolved mysteries of biology today, including our understanding of evolution as well as of the fundamental life process in higher cells," says DasSarma. "There is a tremendous genetic resource in the genomes of microorganisms. In fact, it is one of the last, largely untapped, natural resources on our planet."

Halobacterium NRC-1 is a member of the archaea, the third branch of life in the biological world. Archaea are evolutionary relics, microorganisms that are among the most ancient forms of life, yet they represent a third of all living creatures. Astronomical numbers of Halobacterium - which are microscopic, rod-shaped organisms - can be found in bodies of very salty water, including the Great Salt Lake and the Dead Sea. The single-celled organisms utilize sunlight to synthesize energy, giving off a red bypro
'"/>

Contact: Paula Hartman Cohen
phcohen@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst
1-Oct-2000


Page: 1 2 3

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. 1st International Conference on Cell Therapy for Cardiovascular Disease
8. International research conferences at the Villa Vigoni
9. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
10. STN International launches Derwent World Patents Index First View
11. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24

Post Your Comments:
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: